Breaking News

CORONAVIRUS

FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

WASHINGTON — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that Americans starting their COVID-19 vaccinations use the Pfizer or Moderna shots instead. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on the ...

Even as COVID cases rise, mask mandates stay shelved

NEW YORK — An increase in COVID-19 infections around the U.S. has sent more cities into new high-risk categories that are supposed to trigger indoor mask wearing, but much of the country is stopping short of bringing back restrictions amid deep pandemic fatigue. For weeks, much of upstate New York has been in the high-alert orange zone, a Centers for Disease Control and Prevention designation that reflects serious community spread. The CDC urges people to mask up in indoor public places, including schools, regardless of vaccination status. But few, if any, local jurisdictions in the ...

Moderna seeks to be 1st with COVID shots for littlest kids

Moderna is seeking to be the first to offer COVID-19 vaccine for the youngest American children, as it asked the Food and Drug Administration Thursday to clear low-dose shots for babies, toddlers and preschoolers. Frustrated families are waiting impatiently for a chance to protect the nation’s littlest kids as all around them people shed masks and other public health precautions — even though highly contagious coronavirus mutants continue to spread. Already about three-quarters of children of all ages show signs they’ve been infected at some point during the pandemic. Moderna ...

Administration expands availability of COVID antiviral pill

WASHINGTON — President Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid, seeking to reassure doctors that there is ample supply for people at high risk of severe illness or death from the virus. Paxlovid, produced by Pfizer, was first approved in December. Supply of the regimen was initially very limited, but COVID-19 cases across the country have fallen and manufacturing has increased. The White House is now moving to raise awareness of the pill and taking steps to make it easier to access. The White House ...

DC estimates 3 in 4 kids have had coronavirus infections

NEW YORK —Three out of every four U.S. children have been infected with the coronavirus and more than half of all Americans had signs of previous infections, Centers for Disease Control and Prevention researchers estimated in a report Tuesday. The researchers examined blood samples from more than 200,000 Americans and looked for virus-fighting antibodies made from infections, not vaccines. They found that signs of past infection rose dramatically between December and February, when the more contagious omicron variant surged through the U.S. The most striking increase was in ...

COVID shots still work but researchers hunt improvements

COVID-19 vaccinations are at a critical juncture as companies test whether new approaches like combination shots or nasal drops can keep up with a mutating coronavirus — even though it’s not clear if changes are needed. Already there’s public confusion about who should get a second booster now and who can wait. There’s also debate about whether pretty much everyone might need an extra dose in the fall. “I’m very concerned about booster fatigue” causing a loss of confidence in vaccines that still offer very strong protection against COVID-19’s worst outcomes, said Dr. ...